Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models.
<h4>Objective</h4>To conduct a systematic review of economic models of newer anticoagulants for stroke prevention in atrial fibrillation (SPAF).<h4>Patients and methods</h4>We searched Medline, Embase, NHSEED and HTA databases and the Tuft's Registry from January 1, 2008...
Saved in:
| Main Authors: | Brendan L Limone, William L Baker, Jeffrey Kluger, Craig I Coleman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0062183 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION
by: S. K. Zyryanov, et al.
Published: (2017-07-01) -
PREVENTION OF STROKE IN ATRIAL FIBRILLATION: THE APPROACHES TO THE CHOICE OF ANTICOAGULANT, DEPENDING ON AGE
by: A. V. Ardashev, et al.
Published: (2016-12-01) -
Problems of selecting an anticoagulant for secondary stroke prevention in patients with atrial fibrillation
by: V. V. Gusev, et al.
Published: (2021-10-01) -
NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01) -
Stroke Prevention With Oral Anticoagulants in High-Risk Atrial Fibrillation in an Aging Population
by: Ken Okumura, MD, PhD, et al.
Published: (2025-06-01)